Prot #INS1009-202: A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

Project: Research project

Project Details

StatusActive
Effective start/end date4/1/22 → 4/1/25

Funding

  • PPD Development ((OE) Prot #INS1009-202 AMD 2 // (OE) Prot #INS1009-202 AMD 2)
  • Insmed Incorporated ((OE) Prot #INS1009-202 AMD 2 // (OE) Prot #INS1009-202 AMD 2)